Key Insights

Highlights

Success Rate

91% trial completion (above average)

Research Maturity

68 completed trials (30% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.1%

7 terminated out of 225 trials

Success Rate

90.7%

+4.2% vs benchmark

Late-Stage Pipeline

9%

21 trials in Phase 3/4

Results Transparency

3%

2 of 68 completed with results

Key Signals

2 with results91% success

Data Visualizations

Phase Distribution

177Total
Not Applicable (66)
Early P 1 (1)
P 1 (19)
P 2 (70)
P 3 (16)
P 4 (5)

Trial Status

Completed68
Unknown55
Recruiting53
Not Yet Recruiting30
Terminated7
Enrolling By Invitation5

Trial Success Rate

90.7%

Benchmark: 86.5%

Based on 68 completed trials

Clinical Trials (225)

Showing 20 of 20 trials
NCT04113226Phase 2CompletedPrimary

Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma

NCT07644533Not ApplicableNot Yet Recruiting

Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced Cancer

NCT05856656Not ApplicableCompleted

Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer

NCT07269340Not ApplicableCompleted

Mandala Painting During Chemotherapy

NCT07175376Not ApplicableRecruiting

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

NCT07435597Not ApplicableRecruiting

Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients

NCT04889924Not ApplicableRecruiting

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

NCT03722121Completed

Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?

NCT06758830Phase 2Recruiting

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

NCT06271356Not ApplicableCompleted

Breast Cancer - Navigate - Prospective Cohort

NCT05941741Phase 3Recruiting

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

NCT07572175Phase 2Not Yet Recruiting

Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity

NCT07562503Phase 2Recruiting

Randomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal Cancer

NCT07561983Phase 2Not Yet Recruiting

Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC

NCT07562490Phase 2Recruiting

A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer

NCT07562711Phase 2Recruiting

Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer

NCT07443618Recruiting

Measuring Fluid Buildup in Cancer Patients

NCT07346677Phase 2Not Yet Recruiting

Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel

NCT07553481Not Yet Recruiting

Chemotherapy-Induced Hearing Loss and Health Inequality

NCT07239466Phase 2Recruiting

A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer

Scroll to load more

Research Network

Activity Timeline